← Leaderboards
Jami Lynn Saloman
University Of Pittsburgh At Pittsburgh
$3,719,308
Attributed
$4,960,986
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,960,986 · 6
By mechanism
R01$3,426,956 · 2
K01$735,050 · 1
R21$446,142 · 1
T32$301,496 · 1
F31$51,342 · 1
Top collaborators
- Hanno Steen3 shared
- Bradley K Taylor1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- David Gur$10,675,065
- Paul R. Kinchington$19,833,198
- Christopher S Martin$6,252,568
- Dario Aa Vignali$40,087,127
- Robert H. Getzenberg$8,211,645
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainSymptomsChronicQuality Of LifePhenotypeDesignSamplingPancreasInflammationOpioidChronic PancreatitisPain ManagementSerumSeveritiesNeuropathyCohortNerve Growth FactorsCytokineNeuropeptidesProspectiveBiological MarkersPeripheralAffectFunctional Disorder
Grant awards (15)
Biomarkers to stratify pain severity and type in pancreatic disease$716,188
R01 · FY2025 · DK
Peripheral Nerve Regulation of Pancreas Cancer Progression$622,548
R01 · FY2025 · CA · contact PI
Training in Mechanisms and Clinical Presentation of Pain$301,496
T32 · FY2025 · NS
Biomarkers to stratify pain severity and type in pancreatic disease$687,602
R01 · FY2024 · DK
Peripheral Nerve Regulation of Pancreas Cancer Progression$622,548
R01 · FY2024 · CA · contact PI
Biomarkers to stratify pain severity and type in pancreatic disease$778,070
R01 · FY2023 · DK
Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?$149,175
K01 · FY2023 · DK · contact PI
Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?$149,175
K01 · FY2022 · DK · contact PI
Mechanism-based Approach to Pain in Chronic Pancreatitis (MAP-CP Study)$196,451
R21 · FY2021 · DK · contact PI
Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?$149,175
K01 · FY2021 · DK · contact PI
Mechanism-based Approach to Pain in Chronic Pancreatitis (MAP-CP Study)$249,691
R21 · FY2020 · DK · contact PI
Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?$149,175
K01 · FY2020 · DK · contact PI
Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?$138,350
K01 · FY2019 · DK · contact PI
Functional Interactions Between Peripheral P2X3 and TRP Channels$19,315
F31 · FY2012 · DE · contact PI
Functional Interactions Between Peripheral P2X3 and TRP Channels$32,027
F31 · FY2011 · DE · contact PI